A detailed history of Next Level Private LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Next Level Private LLC holds 700 shares of LLY stock, worth $620,158. This represents 0.3% of its overall portfolio holdings.

Number of Shares
700
Previous 696 0.57%
Holding current value
$620,158
Previous $541,000 17.01%
% of portfolio
0.3%
Previous 0.26%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 01, 2024

BUY
$724.87 - $909.04 $2,899 - $3,636
4 Added 0.57%
700 $633,000
Q1 2024

Apr 15, 2024

BUY
$592.2 - $792.28 $142,720 - $190,939
241 Added 52.97%
696 $541,000
Q4 2023

Jan 18, 2024

SELL
$525.19 - $619.13 $24,683 - $29,099
-47 Reduced 9.36%
455 $265,000
Q3 2023

Oct 10, 2023

BUY
$434.7 - $599.3 $21,300 - $29,365
49 Added 10.82%
502 $269,000
Q2 2023

Jul 14, 2023

BUY
$350.74 - $468.98 $158,885 - $212,447
453 New
453 $212,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $842B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Next Level Private LLC Portfolio

Follow Next Level Private LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Next Level Private LLC, based on Form 13F filings with the SEC.

News

Stay updated on Next Level Private LLC with notifications on news.